VK

Vijay Khanija

Active Director Director DIN 10465944
DIN 10465944 First appointment Sep 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Vijay Khanija

Data last updated:

Vijay Khanija is a Director at I.J. Pharmaceuticals Private Limited (since 2025). The company operates in Chemicals. I.J. Pharmaceuticals Private Limited reported revenue of ₹36.1 Lakh (FY 2025).

DIN 10465944
Primary Designation Director
Industry Chemicals
First Appointment 18 Sep 2025
Oldest Company Age 34 yrs
Largest company I.J. Pharmaceuticals Private Limited · ₹36.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
I.J. Pharmaceuticals Private Limited U24100DL1991PTC046900
Director18 Sep 20251991₹36.1 Lakh (FY 2025)Active

Board colleagues of Vijay Khanija

NameDINCompanyDesignation
Surinder Kumar Khanija00567728I.J. Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
I.J. Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vijay Khanija

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Khanija

Vijay Khanija currently holds 1 directorship: I.J. Pharmaceuticals Private Limited (Director, since 18 Sep 2025, revenue ₹36.1 Lakh (FY 2025)).

Vijay Khanija was first appointed on 18 Sep 2025 as Director at I.J. Pharmaceuticals Private Limited.

The current boards of Vijay Khanija's companies include Surinder Kumar Khanija (I.J. Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available